Baylor St. Luke's Medical Center is the private adult teaching hospital of Baylor College of Medicine jointly owned with CHI St. Luke's Health. The medical staff at the hospital includes full-time Baylor faculty, as well as community physicians.

During the past decade, St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "Aptuit" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital" are "Leukemia" (4 trials), "Prostate Cancer" (4 trials), "Lung Cancer" (3 trials), "Metastatic Cancer" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital" in a lesser frequency.

Most popular intervention types in "St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital" are "Drug" (10 trials), "Other" (7 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "biologic sample preservation procedure" (3 trials), "placebo" (3 trials), "cetuximab" (2 trials), "clofarabine" (2 trials) and "cytarabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital" are 11 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".